Event Date/Time: Mar 11, 2009 | End Date/Time: Mar 12, 2009 |
Description
A key focus for companies working in the industry is to not only to reduce the impurities and improve the properties of drugs for further development, but also to look at the correct analytical and characterisation techniques. Ensuring effective patent protection and patent term extension, whilst gaining increased market share in this current financial climate.
Confirmed Speakers Include:
• Professor Roger Davey, Molecular Engineering, University of Manchester
• Dr Michael Millan, Director of Pharma, Avantium
• Dr Surya Devarakonda, Associate Director, API Research and Development, Dr Reddys
• Dr Fiona Thorley, Research Director, Aptuit
• Dr Ingvar Ymén, Analytical Chemist, AstraZeneca
• Professor Leslie Leiserowitz, The Patricia Elman Bildner Professor of Solid State Chemistry, Weizmann Institute
• Dr Rolf Hilfiker, Head of Department, Solid State Development, Vice President, Solvias
• Professor William Jones, Materials Chemistry Group, University of Cambridge